nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Skin irritation—Valrubicin—urinary bladder cancer	0.0268	0.0793	CcSEcCtD
Adapalene—RARB—prostate gland—urinary bladder cancer	0.0199	0.104	CbGeAlD
Adapalene—RXRG—prostate gland—urinary bladder cancer	0.0195	0.102	CbGeAlD
Adapalene—RARG—prostate gland—urinary bladder cancer	0.0162	0.0851	CbGeAlD
Adapalene—RARA—prostate gland—urinary bladder cancer	0.0153	0.0801	CbGeAlD
Adapalene—RXRA—renal system—urinary bladder cancer	0.0151	0.0792	CbGeAlD
Adapalene—RXRA—female reproductive system—urinary bladder cancer	0.0121	0.0634	CbGeAlD
Adapalene—Burning sensation—Mitomycin—urinary bladder cancer	0.0115	0.034	CcSEcCtD
Adapalene—Herpes labialis—Epirubicin—urinary bladder cancer	0.0111	0.033	CcSEcCtD
Adapalene—RARG—urethra—urinary bladder cancer	0.0109	0.057	CbGeAlD
Adapalene—RARB—female reproductive system—urinary bladder cancer	0.0109	0.057	CbGeAlD
Adapalene—RARA—renal system—urinary bladder cancer	0.0104	0.0546	CbGeAlD
Adapalene—Herpes labialis—Doxorubicin—urinary bladder cancer	0.0103	0.0305	CcSEcCtD
Adapalene—Papilloedema—Cisplatin—urinary bladder cancer	0.0099	0.0293	CcSEcCtD
Adapalene—Stinging—Mitomycin—urinary bladder cancer	0.00985	0.0292	CcSEcCtD
Adapalene—RARB—vagina—urinary bladder cancer	0.00983	0.0515	CbGeAlD
Adapalene—RXRB—vagina—urinary bladder cancer	0.00903	0.0474	CbGeAlD
Adapalene—RARG—female reproductive system—urinary bladder cancer	0.00886	0.0465	CbGeAlD
Adapalene—RARA—female reproductive system—urinary bladder cancer	0.00833	0.0437	CbGeAlD
Adapalene—RARG—vagina—urinary bladder cancer	0.00802	0.042	CbGeAlD
Adapalene—Skin irritation—Fluorouracil—urinary bladder cancer	0.00767	0.0227	CcSEcCtD
Adapalene—Application site pain—Fluorouracil—urinary bladder cancer	0.00755	0.0223	CcSEcCtD
Adapalene—Oral herpes—Epirubicin—urinary bladder cancer	0.00686	0.0203	CcSEcCtD
Adapalene—RARB—lymph node—urinary bladder cancer	0.00636	0.0333	CbGeAlD
Adapalene—Oral herpes—Doxorubicin—urinary bladder cancer	0.00635	0.0188	CcSEcCtD
Adapalene—Sunburn—Methotrexate—urinary bladder cancer	0.00572	0.0169	CcSEcCtD
Adapalene—RARG—lymph node—urinary bladder cancer	0.00518	0.0272	CbGeAlD
Adapalene—Optic neuritis—Cisplatin—urinary bladder cancer	0.00512	0.0151	CcSEcCtD
Adapalene—RARA—lymph node—urinary bladder cancer	0.00487	0.0256	CbGeAlD
Adapalene—Optic neuritis—Etoposide—urinary bladder cancer	0.00469	0.0139	CcSEcCtD
Adapalene—Dermatitis atopic—Gemcitabine—urinary bladder cancer	0.00456	0.0135	CcSEcCtD
Adapalene—Skin discolouration—Thiotepa—urinary bladder cancer	0.00444	0.0132	CcSEcCtD
Adapalene—Stinging—Fluorouracil—urinary bladder cancer	0.0041	0.0121	CcSEcCtD
Adapalene—Dermatitis contact—Thiotepa—urinary bladder cancer	0.00397	0.0117	CcSEcCtD
Adapalene—Skin exfoliation—Thiotepa—urinary bladder cancer	0.00383	0.0113	CcSEcCtD
Adapalene—Herpes simplex—Fluorouracil—urinary bladder cancer	0.0036	0.0107	CcSEcCtD
Adapalene—Erythema—Mitomycin—urinary bladder cancer	0.00349	0.0103	CcSEcCtD
Adapalene—Dermatitis contact—Fluorouracil—urinary bladder cancer	0.00328	0.00971	CcSEcCtD
Adapalene—Pain—Carboplatin—urinary bladder cancer	0.00327	0.00969	CcSEcCtD
Adapalene—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.00322	0.00954	CcSEcCtD
Adapalene—Skin discolouration—Etoposide—urinary bladder cancer	0.00319	0.00945	CcSEcCtD
Adapalene—Skin exfoliation—Cisplatin—urinary bladder cancer	0.003	0.0089	CcSEcCtD
Adapalene—Pruritus—Valrubicin—urinary bladder cancer	0.00292	0.00866	CcSEcCtD
Adapalene—Vesiculobullous rash—Epirubicin—urinary bladder cancer	0.00288	0.00854	CcSEcCtD
Adapalene—Skin exfoliation—Etoposide—urinary bladder cancer	0.00275	0.00815	CcSEcCtD
Adapalene—Vesiculobullous rash—Doxorubicin—urinary bladder cancer	0.00267	0.0079	CcSEcCtD
Adapalene—Optic neuritis—Epirubicin—urinary bladder cancer	0.00263	0.00778	CcSEcCtD
Adapalene—Rash—Valrubicin—urinary bladder cancer	0.00261	0.00772	CcSEcCtD
Adapalene—Dermatitis—Valrubicin—urinary bladder cancer	0.0026	0.00771	CcSEcCtD
Adapalene—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.00256	0.00759	CcSEcCtD
Adapalene—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.00252	0.00746	CcSEcCtD
Adapalene—Keratitis—Epirubicin—urinary bladder cancer	0.00249	0.00738	CcSEcCtD
Adapalene—Burning sensation—Methotrexate—urinary bladder cancer	0.00249	0.00736	CcSEcCtD
Adapalene—Pain—Mitomycin—urinary bladder cancer	0.00243	0.00721	CcSEcCtD
Adapalene—Optic neuritis—Doxorubicin—urinary bladder cancer	0.00243	0.0072	CcSEcCtD
Adapalene—Redness—Epirubicin—urinary bladder cancer	0.00239	0.00709	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Epirubicin—urinary bladder cancer	0.00237	0.00702	CcSEcCtD
Adapalene—Face oedema—Gemcitabine—urinary bladder cancer	0.00237	0.00701	CcSEcCtD
Adapalene—Burning sensation—Epirubicin—urinary bladder cancer	0.00233	0.00689	CcSEcCtD
Adapalene—Keratitis—Doxorubicin—urinary bladder cancer	0.00231	0.00683	CcSEcCtD
Adapalene—Redness—Doxorubicin—urinary bladder cancer	0.00221	0.00656	CcSEcCtD
Adapalene—Dry skin—Fluorouracil—urinary bladder cancer	0.00221	0.00654	CcSEcCtD
Adapalene—Face oedema—Cisplatin—urinary bladder cancer	0.00221	0.00653	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—urinary bladder cancer	0.00219	0.00649	CcSEcCtD
Adapalene—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.00218	0.00646	CcSEcCtD
Adapalene—Conjunctivitis—Thiotepa—urinary bladder cancer	0.00218	0.00646	CcSEcCtD
Adapalene—Burning sensation—Doxorubicin—urinary bladder cancer	0.00215	0.00637	CcSEcCtD
Adapalene—Feeling hot—Epirubicin—urinary bladder cancer	0.00206	0.0061	CcSEcCtD
Adapalene—Rash pustular—Epirubicin—urinary bladder cancer	0.00203	0.006	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.00202	0.00598	CcSEcCtD
Adapalene—Stinging—Epirubicin—urinary bladder cancer	0.00199	0.00591	CcSEcCtD
Adapalene—Skin discolouration—Methotrexate—urinary bladder cancer	0.00191	0.00566	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—urinary bladder cancer	0.0019	0.00564	CcSEcCtD
Adapalene—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.0019	0.00563	CcSEcCtD
Adapalene—Rash pustular—Doxorubicin—urinary bladder cancer	0.00187	0.00555	CcSEcCtD
Adapalene—Herpes simplex—Methotrexate—urinary bladder cancer	0.00187	0.00555	CcSEcCtD
Adapalene—Stinging—Doxorubicin—urinary bladder cancer	0.00185	0.00546	CcSEcCtD
Adapalene—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.0018	0.00534	CcSEcCtD
Adapalene—Rash—Mitomycin—urinary bladder cancer	0.0018	0.00532	CcSEcCtD
Adapalene—Dermatitis—Mitomycin—urinary bladder cancer	0.00179	0.00531	CcSEcCtD
Adapalene—Skin discolouration—Epirubicin—urinary bladder cancer	0.00179	0.0053	CcSEcCtD
Adapalene—Erythema—Thiotepa—urinary bladder cancer	0.00175	0.00519	CcSEcCtD
Adapalene—Herpes simplex—Epirubicin—urinary bladder cancer	0.00175	0.00519	CcSEcCtD
Adapalene—Conjunctivitis—Cisplatin—urinary bladder cancer	0.00171	0.00507	CcSEcCtD
Adapalene—Skin discolouration—Doxorubicin—urinary bladder cancer	0.00166	0.0049	CcSEcCtD
Adapalene—Skin exfoliation—Methotrexate—urinary bladder cancer	0.00165	0.00488	CcSEcCtD
Adapalene—Herpes simplex—Doxorubicin—urinary bladder cancer	0.00162	0.0048	CcSEcCtD
Adapalene—Dermatitis contact—Epirubicin—urinary bladder cancer	0.0016	0.00473	CcSEcCtD
Adapalene—Skin exfoliation—Epirubicin—urinary bladder cancer	0.00154	0.00457	CcSEcCtD
Adapalene—Convulsion—Thiotepa—urinary bladder cancer	0.00152	0.0045	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.00148	0.00438	CcSEcCtD
Adapalene—Erythema—Gemcitabine—urinary bladder cancer	0.00148	0.00437	CcSEcCtD
Adapalene—Erythema—Fluorouracil—urinary bladder cancer	0.00145	0.0043	CcSEcCtD
Adapalene—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.00143	0.00423	CcSEcCtD
Adapalene—Erythema—Cisplatin—urinary bladder cancer	0.00138	0.00407	CcSEcCtD
Adapalene—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00133	0.00393	CcSEcCtD
Adapalene—Eczema—Epirubicin—urinary bladder cancer	0.00131	0.00386	CcSEcCtD
Adapalene—Eye pain—Epirubicin—urinary bladder cancer	0.0013	0.00385	CcSEcCtD
Adapalene—Convulsion—Fluorouracil—urinary bladder cancer	0.00126	0.00372	CcSEcCtD
Adapalene—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00124	0.00368	CcSEcCtD
Adapalene—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00123	0.00363	CcSEcCtD
Adapalene—Pain—Thiotepa—urinary bladder cancer	0.00122	0.00363	CcSEcCtD
Adapalene—Eczema—Doxorubicin—urinary bladder cancer	0.00121	0.00358	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—urinary bladder cancer	0.0012	0.00356	CcSEcCtD
Adapalene—Convulsion—Cisplatin—urinary bladder cancer	0.00119	0.00353	CcSEcCtD
Adapalene—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00115	0.00341	CcSEcCtD
Adapalene—Urticaria—Thiotepa—urinary bladder cancer	0.00114	0.00337	CcSEcCtD
Adapalene—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00114	0.00336	CcSEcCtD
Adapalene—Face oedema—Epirubicin—urinary bladder cancer	0.00113	0.00335	CcSEcCtD
Adapalene—RXRG—Adipogenesis—RB1—urinary bladder cancer	0.00112	0.00237	CbGpPWpGaD
Adapalene—RXRA—Mitochondrial biogenesis—CREBBP—urinary bladder cancer	0.00111	0.00235	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IGF1—urinary bladder cancer	0.00111	0.00234	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.0011	0.00233	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—PPARG—urinary bladder cancer	0.0011	0.00232	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—CREBBP—urinary bladder cancer	0.00109	0.00232	CbGpPWpGaD
Adapalene—Convulsion—Etoposide—urinary bladder cancer	0.00109	0.00323	CcSEcCtD
Adapalene—Dry skin—Epirubicin—urinary bladder cancer	0.00108	0.00318	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—urinary bladder cancer	0.00107	0.00228	CbGpPWpGaD
Adapalene—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00105	0.00312	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00105	0.00223	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—RB1—urinary bladder cancer	0.00105	0.00222	CbGpPWpGaD
Adapalene—Face oedema—Doxorubicin—urinary bladder cancer	0.00105	0.0031	CcSEcCtD
Adapalene—RARA—Adipogenesis—IGF1—urinary bladder cancer	0.00104	0.0022	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—HPGDS—urinary bladder cancer	0.00103	0.00219	CbGpPWpGaD
Adapalene—Pain—Gemcitabine—urinary bladder cancer	0.00103	0.00305	CcSEcCtD
Adapalene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.00102	0.00217	CbGpPWpGaD
Adapalene—Pruritus—Thiotepa—urinary bladder cancer	0.00101	0.003	CcSEcCtD
Adapalene—Pain—Fluorouracil—urinary bladder cancer	0.00101	0.003	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00101	0.00214	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTT1—urinary bladder cancer	0.001	0.00212	CbGpPWpGaD
Adapalene—Dry skin—Doxorubicin—urinary bladder cancer	0.000995	0.00295	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000989	0.00293	CcSEcCtD
Adapalene—Pain—Cisplatin—urinary bladder cancer	0.00096	0.00284	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—urinary bladder cancer	0.000956	0.00203	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000948	0.00201	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—NQO1—urinary bladder cancer	0.000948	0.00201	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000942	0.002	CbGpPWpGaD
Adapalene—Urticaria—Fluorouracil—urinary bladder cancer	0.000941	0.00279	CcSEcCtD
Adapalene—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000939	0.00278	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000929	0.00197	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000925	0.00274	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000925	0.00196	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000921	0.00195	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.000911	0.00193	CbGpPWpGaD
Adapalene—Rash—Thiotepa—urinary bladder cancer	0.000903	0.00267	CcSEcCtD
Adapalene—Dermatitis—Thiotepa—urinary bladder cancer	0.000902	0.00267	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000892	0.00189	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.00089	0.00189	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000887	0.00188	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000883	0.00187	CbGpPWpGaD
Adapalene—Pain—Etoposide—urinary bladder cancer	0.00088	0.0026	CcSEcCtD
Adapalene—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000879	0.0026	CcSEcCtD
Adapalene—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000873	0.00258	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—urinary bladder cancer	0.000868	0.00184	CbGpPWpGaD
Adapalene—Hepatitis—Methotrexate—urinary bladder cancer	0.000867	0.00257	CcSEcCtD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00086	0.00182	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000856	0.00254	CcSEcCtD
Adapalene—Pruritus—Gemcitabine—urinary bladder cancer	0.000852	0.00252	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000841	0.00178	CbGpPWpGaD
Adapalene—Pruritus—Fluorouracil—urinary bladder cancer	0.000838	0.00248	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—CREBBP—urinary bladder cancer	0.000834	0.00177	CbGpPWpGaD
Adapalene—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000827	0.00245	CcSEcCtD
Adapalene—Urticaria—Etoposide—urinary bladder cancer	0.000817	0.00242	CcSEcCtD
Adapalene—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000813	0.00241	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—urinary bladder cancer	0.000811	0.0024	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000807	0.00171	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—CDKN1A—urinary bladder cancer	0.000801	0.0017	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000797	0.00169	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—NCOR1—urinary bladder cancer	0.000797	0.00169	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—GSTP1—urinary bladder cancer	0.00079	0.00168	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000774	0.00164	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000769	0.00163	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000766	0.00162	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000764	0.00162	CbGpPWpGaD
Adapalene—Rash—Gemcitabine—urinary bladder cancer	0.000759	0.00225	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000759	0.00161	CbGpPWpGaD
Adapalene—Dermatitis—Gemcitabine—urinary bladder cancer	0.000759	0.00225	CcSEcCtD
Adapalene—Hypersensitivity—Etoposide—urinary bladder cancer	0.000758	0.00224	CcSEcCtD
Adapalene—Erythema—Methotrexate—urinary bladder cancer	0.000755	0.00224	CcSEcCtD
Adapalene—RARB—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000754	0.0016	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—CDKN1A—urinary bladder cancer	0.000754	0.0016	CbGpPWpGaD
Adapalene—Hepatitis—Doxorubicin—urinary bladder cancer	0.000751	0.00222	CcSEcCtD
Adapalene—Rash—Fluorouracil—urinary bladder cancer	0.000747	0.00221	CcSEcCtD
Adapalene—Dermatitis—Fluorouracil—urinary bladder cancer	0.000746	0.00221	CcSEcCtD
Adapalene—RXRA—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000745	0.00158	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000744	0.00158	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—urinary bladder cancer	0.000744	0.00158	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—EP300—urinary bladder cancer	0.000744	0.00158	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CNTN2—urinary bladder cancer	0.000732	0.00155	CbGpPWpGaD
Adapalene—RXRA—Organelle biogenesis and maintenance—NCOR1—urinary bladder cancer	0.00073	0.00155	CbGpPWpGaD
Adapalene—Pruritus—Etoposide—urinary bladder cancer	0.000728	0.00215	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—GSTM1—urinary bladder cancer	0.000726	0.00154	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000723	0.00153	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000723	0.00153	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—FAS—urinary bladder cancer	0.000714	0.00151	CbGpPWpGaD
Adapalene—Rash—Cisplatin—urinary bladder cancer	0.000708	0.0021	CcSEcCtD
Adapalene—Dermatitis—Cisplatin—urinary bladder cancer	0.000707	0.00209	CcSEcCtD
Adapalene—Erythema—Epirubicin—urinary bladder cancer	0.000706	0.00209	CcSEcCtD
Adapalene—RXRA—Biological oxidations—GSTP1—urinary bladder cancer	0.000693	0.00147	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000676	0.00143	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000661	0.0014	CbGpPWpGaD
Adapalene—RXRA—Orphan transporters—CREBBP—urinary bladder cancer	0.000656	0.00139	CbGpPWpGaD
Adapalene—Convulsion—Methotrexate—urinary bladder cancer	0.000654	0.00194	CcSEcCtD
Adapalene—Erythema—Doxorubicin—urinary bladder cancer	0.000654	0.00194	CcSEcCtD
Adapalene—RXRA—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000653	0.00138	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000649	0.00138	CbGpPWpGaD
Adapalene—Rash—Etoposide—urinary bladder cancer	0.000648	0.00192	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000648	0.00137	CbGpPWpGaD
Adapalene—Dermatitis—Etoposide—urinary bladder cancer	0.000648	0.00192	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000639	0.00135	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTM1—urinary bladder cancer	0.000637	0.00135	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000634	0.00134	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000627	0.00133	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000621	0.00132	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TNF—urinary bladder cancer	0.000619	0.00131	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000614	0.0013	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000614	0.0013	CbGpPWpGaD
Adapalene—Convulsion—Epirubicin—urinary bladder cancer	0.000612	0.00181	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000603	0.00128	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—urinary bladder cancer	0.000598	0.00127	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000597	0.00127	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000594	0.00126	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000593	0.00126	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000582	0.00124	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TNF—urinary bladder cancer	0.000582	0.00123	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000578	0.00123	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000576	0.00122	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000573	0.00121	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—PPARG—urinary bladder cancer	0.000571	0.00121	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.000568	0.0012	CbGpPWpGaD
Adapalene—Convulsion—Doxorubicin—urinary bladder cancer	0.000566	0.00168	CcSEcCtD
Adapalene—RXRB—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000558	0.00118	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000558	0.00118	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000554	0.00117	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000553	0.00117	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.00055	0.00117	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—RB1—urinary bladder cancer	0.000547	0.00116	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IGF1—urinary bladder cancer	0.000542	0.00115	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000535	0.00113	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000527	0.00112	CbGpPWpGaD
Adapalene—Pain—Methotrexate—urinary bladder cancer	0.000527	0.00156	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000525	0.00111	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000513	0.00109	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00051	0.00108	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000507	0.00107	CbGpPWpGaD
Adapalene—RXRA—Organelle biogenesis and maintenance—CREBBP—urinary bladder cancer	0.000503	0.00107	CbGpPWpGaD
Adapalene—Pain—Epirubicin—urinary bladder cancer	0.000493	0.00146	CcSEcCtD
Adapalene—Urticaria—Methotrexate—urinary bladder cancer	0.000489	0.00145	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000479	0.00102	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000469	0.000994	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000467	0.000989	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000465	0.000987	CbGpPWpGaD
Adapalene—RARG—Gene Expression—SMC1A—urinary bladder cancer	0.000465	0.000985	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000464	0.000984	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000462	0.00098	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.000461	0.000978	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00046	0.000976	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000459	0.000974	CbGpPWpGaD
Adapalene—Urticaria—Epirubicin—urinary bladder cancer	0.000458	0.00136	CcSEcCtD
Adapalene—RARB—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000457	0.00097	CbGpPWpGaD
Adapalene—Pain—Doxorubicin—urinary bladder cancer	0.000456	0.00135	CcSEcCtD
Adapalene—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000454	0.00134	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000449	0.000953	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000447	0.000948	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000446	0.000946	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000443	0.000939	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.00044	0.000934	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000439	0.00093	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000439	0.00093	CbGpPWpGaD
Adapalene—Pruritus—Methotrexate—urinary bladder cancer	0.000436	0.00129	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000428	0.000907	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—EP300—urinary bladder cancer	0.000427	0.000906	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000426	0.000903	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SMC1A—urinary bladder cancer	0.000425	0.000901	CbGpPWpGaD
Adapalene—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000425	0.00126	CcSEcCtD
Adapalene—RXRA—Metabolism—GSTZ1—urinary bladder cancer	0.000425	0.000901	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000424	0.0009	CbGpPWpGaD
Adapalene—Urticaria—Doxorubicin—urinary bladder cancer	0.000424	0.00125	CcSEcCtD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000423	0.000897	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000418	0.000886	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000417	0.000885	CbGpPWpGaD
Adapalene—RARB—Gene Expression—SMC1A—urinary bladder cancer	0.000417	0.000884	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000409	0.000867	CbGpPWpGaD
Adapalene—Pruritus—Epirubicin—urinary bladder cancer	0.000408	0.00121	CcSEcCtD
Adapalene—RARG—Gene Expression—ESR2—urinary bladder cancer	0.000405	0.000859	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000403	0.000855	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTO2—urinary bladder cancer	0.000403	0.000854	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NAT1—urinary bladder cancer	0.000403	0.000854	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000401	0.00085	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.0004	0.000849	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.0004	0.000849	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SMC1A—urinary bladder cancer	0.0004	0.000847	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SMC1A—urinary bladder cancer	0.0004	0.000847	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000398	0.000845	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000396	0.00084	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000393	0.000834	CbGpPWpGaD
Adapalene—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000393	0.00116	CcSEcCtD
Adapalene—RXRA—Adipogenesis—CDKN1A—urinary bladder cancer	0.000393	0.000833	CbGpPWpGaD
Adapalene—Rash—Methotrexate—urinary bladder cancer	0.000388	0.00115	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—urinary bladder cancer	0.000388	0.00115	CcSEcCtD
Adapalene—RARA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000384	0.000815	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000384	0.000815	CbGpPWpGaD
Adapalene—Pruritus—Doxorubicin—urinary bladder cancer	0.000377	0.00112	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000377	0.0008	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000377	0.000799	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR2—urinary bladder cancer	0.00037	0.000785	CbGpPWpGaD
Adapalene—RXRA—Metabolism—UGT2B7—urinary bladder cancer	0.000368	0.000781	CbGpPWpGaD
Adapalene—Rash—Epirubicin—urinary bladder cancer	0.000364	0.00108	CcSEcCtD
Adapalene—RARB—Gene Expression—ESR2—urinary bladder cancer	0.000363	0.00077	CbGpPWpGaD
Adapalene—Dermatitis—Epirubicin—urinary bladder cancer	0.000363	0.00108	CcSEcCtD
Adapalene—RARA—Gene Expression—ESR2—urinary bladder cancer	0.000348	0.000738	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR2—urinary bladder cancer	0.000348	0.000738	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000342	0.000726	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000338	0.000716	CbGpPWpGaD
Adapalene—Rash—Doxorubicin—urinary bladder cancer	0.000336	0.000996	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—urinary bladder cancer	0.000336	0.000995	CcSEcCtD
Adapalene—RXRA—Metabolism—CYP4B1—urinary bladder cancer	0.000332	0.000703	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.00033	0.0007	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC19A1—urinary bladder cancer	0.000313	0.000664	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NCOR1—urinary bladder cancer	0.000313	0.000663	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PRSS3—urinary bladder cancer	0.000305	0.000647	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—urinary bladder cancer	0.000303	0.000643	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000298	0.000633	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ERCC2—urinary bladder cancer	0.000294	0.000623	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000291	0.000617	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000289	0.000612	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000288	0.000611	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000288	0.000611	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NCOR1—urinary bladder cancer	0.000286	0.000606	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NCOR1—urinary bladder cancer	0.00028	0.000595	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000275	0.000582	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NCOR1—urinary bladder cancer	0.000274	0.000581	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NCOR1—urinary bladder cancer	0.000269	0.00057	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NCOR1—urinary bladder cancer	0.000269	0.00057	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ERCC2—urinary bladder cancer	0.000269	0.00057	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000267	0.000566	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000265	0.000563	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ERCC2—urinary bladder cancer	0.000264	0.000559	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ERCC2—urinary bladder cancer	0.000253	0.000536	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ERCC2—urinary bladder cancer	0.000253	0.000536	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR1—urinary bladder cancer	0.000246	0.000521	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000245	0.000519	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TYMP—urinary bladder cancer	0.000244	0.000517	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000243	0.000515	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000239	0.000508	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000238	0.000505	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000234	0.000497	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000234	0.000496	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000229	0.000485	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000228	0.000484	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000228	0.000484	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR1—urinary bladder cancer	0.000225	0.000476	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PPARG—urinary bladder cancer	0.000224	0.000475	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000223	0.000473	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000221	0.000469	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NAT2—urinary bladder cancer	0.000221	0.000468	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ESR1—urinary bladder cancer	0.00022	0.000467	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CDK4—urinary bladder cancer	0.000216	0.000458	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CREBBP—urinary bladder cancer	0.000215	0.000456	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR1—urinary bladder cancer	0.000211	0.000448	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR1—urinary bladder cancer	0.000211	0.000448	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000209	0.000442	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SMC1A—urinary bladder cancer	0.000208	0.000442	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PPARG—urinary bladder cancer	0.000205	0.000435	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PPARG—urinary bladder cancer	0.000201	0.000426	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.0002	0.000425	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CREBBP—urinary bladder cancer	0.000197	0.000417	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000197	0.000417	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PPARG—urinary bladder cancer	0.000196	0.000416	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CREBBP—urinary bladder cancer	0.000193	0.000409	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PPARG—urinary bladder cancer	0.000193	0.000409	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PPARG—urinary bladder cancer	0.000193	0.000409	CbGpPWpGaD
Adapalene—RXRA—Metabolism—RRM2—urinary bladder cancer	0.00019	0.000404	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CREBBP—urinary bladder cancer	0.000189	0.0004	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CREBBP—urinary bladder cancer	0.000185	0.000392	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CREBBP—urinary bladder cancer	0.000185	0.000392	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR2—urinary bladder cancer	0.000181	0.000385	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HPGDS—urinary bladder cancer	0.000176	0.000374	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ENO2—urinary bladder cancer	0.000176	0.000374	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000175	0.000372	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTT1—urinary bladder cancer	0.000171	0.000363	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—RHOA—urinary bladder cancer	0.000171	0.000362	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000168	0.000357	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00016	0.00034	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ERBB2—urinary bladder cancer	0.000158	0.000335	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NQO1—urinary bladder cancer	0.000142	0.000301	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NCOR1—urinary bladder cancer	0.00014	0.000297	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000138	0.000292	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP9—urinary bladder cancer	0.000135	0.000287	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ERCC2—urinary bladder cancer	0.000132	0.000279	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EP300—urinary bladder cancer	0.000128	0.000272	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—urinary bladder cancer	0.000128	0.000271	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SRC—urinary bladder cancer	0.000125	0.000265	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00012	0.000255	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000119	0.000252	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTP1—urinary bladder cancer	0.000119	0.000251	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—urinary bladder cancer	0.000117	0.000248	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000115	0.000243	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—urinary bladder cancer	0.000115	0.000243	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TYMS—urinary bladder cancer	0.00011	0.000234	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR1—urinary bladder cancer	0.00011	0.000233	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—urinary bladder cancer	0.00011	0.000233	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—urinary bladder cancer	0.00011	0.000233	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EGFR—urinary bladder cancer	0.000109	0.000232	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOR1—urinary bladder cancer	0.000109	0.000231	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTM1—urinary bladder cancer	0.000109	0.000231	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GPX1—urinary bladder cancer	0.000104	0.000221	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—urinary bladder cancer	0.000104	0.000221	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—urinary bladder cancer	0.000103	0.000219	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ERCC2—urinary bladder cancer	0.000102	0.000217	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PPARG—urinary bladder cancer	0.0001	0.000213	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CREBBP—urinary bladder cancer	9.65e-05	0.000205	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTHFR—urinary bladder cancer	9.63e-05	0.000204	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HRAS—urinary bladder cancer	8.79e-05	0.000186	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PPARG—urinary bladder cancer	7.81e-05	0.000166	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CREBBP—urinary bladder cancer	7.5e-05	0.000159	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—urinary bladder cancer	6.14e-05	0.00013	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—urinary bladder cancer	5.72e-05	0.000121	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTEN—urinary bladder cancer	5.36e-05	0.000114	CbGpPWpGaD
Adapalene—RXRA—Metabolism—EP300—urinary bladder cancer	5.11e-05	0.000108	CbGpPWpGaD
